Showing results (1271-1280 of 4,561) with videos related to

Sort By:
Pageof 457
Neuropsychiatric Disease and Treatment|April 21, 2020
Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural HematomaSansong Chen, Hui Peng, Xuefei Shao, et al.
Neuropsychiatric Disease and Treatment|August 15, 2022
Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson's DiseaseWolfgang H Jost
Neuropsychiatric Disease and Treatment|August 25, 2022
Downregulation of miR-210 Promoted Apoptosis of Hippocampal Neurons by Negatively Regulating the TLR4/NF-кB1 Signaling Pathway in a Rat Model of Status EpilepticusQin Zhou, Huanjun Luo, Xiaowei Wang, et al.
Neuropsychiatric Disease and Treatment|November 17, 2021
Not All Cases of Visual Snows are Benign: Mimics of Visual Snow SyndromeChenyue Hang, Lakshmi Leishangthem, Yan Yan
Neuropsychiatric Disease and Treatment|November 17, 2021
Proteomic Analysis Reveals that Di Dang Decoction Protects Against Acute Intracerebral Hemorrhage Stroke in Rats by Regulating S100a8, S100a9 Col1a1, and Col1a2Lina Feng, Mingquan Li, Jixiang Ren, et al.
Neuropsychiatric Disease and Treatment|January 17, 2022
Functional Connectivity Density in the Sensorimotor Area is Associated with Sleep Latency in Patients with Primary InsomniaBin Ji, Min Dai, Zhongwei Guo, et al.
Neuropsychiatric Disease and Treatment|December 23, 2021
Selective Impairment of Processing Task-Irrelevant Emotional Faces in Cerebral Small Vessel Disease PatientsZhongyu Fan, Yunliang Guo, Xunyao Hou, et al.
Neuropsychiatric Disease and Treatment|December 23, 2021
Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine PlatformsCharles Ruetsch, Tigwa Davis, Joshua N Liberman, et al.
Neuropsychiatric Disease and Treatment|December 22, 2021
Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched StudyHaruna Matsuzaki, Masakazu Hatano, Miko Iwata, et al.
Neuropsychiatric Disease and Treatment|September 20, 2022
Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive DisorderJeong-Hee Kim, Yo-Han Joo, Young-Don Son, et al.
Pageof 457